Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
免疫療法のためのRNA製剤
Document Type and Number:
Japanese Patent JP6832904
Kind Code:
B2
Abstract:
The present invention is in the field of immunotherapy, in particular tumor immunotherapy. The present invention provides pharmaceutical formulations for delivering RNA to antigen presenting cells such as dendrite cells (DCs) in the spleen after systemic administration. In particular, the formulations described herein enable to induce an immune response after systemic administration of antigen-coding RNA.

Inventors:
Ughur Shaheen
Heinrich Haas
Sebastian writer
Mustafa Dicken
Daniel Fritz
Martin Menk
Lena Malaine Kranz
Kerstin Reuter
Application Number:
JP2018222175A
Publication Date:
February 24, 2021
Filing Date:
November 28, 2018
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
TRON-Translationare on Corogee an der Universitate Smedizin der Johannes Gutenberg-Universitate Mainz Gemainn Nutsige Geembehr
Bayon Tech Ale Ner Pharmaceuticals Game Behr
International Classes:
A61K31/7105; A61K9/127; A61K39/00; A61K47/18; A61K47/24; A61K47/28; A61K47/44; A61K48/00; A61P35/00; A61P37/04
Domestic Patent References:
JP2010059064A
JP2015514076A
Foreign References:
WO2011005799A1
Attorney, Agent or Firm:
Yasuhiko Murayama
Shinya Mitsuhiro
Tatsuhiko Abe